Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis

J Infect Dis. 2009 Aug 1;200(3):379-89. doi: 10.1086/600141.

Abstract

Background: Recombinant forms of Neisseria meningitidis human factor H binding protein (fHBP) are undergoing clinical trials in candidate vaccines against invasive meningococcal serogroup B disease. We report an extensive survey and phylogenetic analysis of the diversity of fhbp genes and predicted protein sequences in invasive clinical isolates obtained in the period 2000-2006.

Methods: Nucleotide sequences of fhbp genes were obtained from 1837 invasive N. meningitidis serogroup B (MnB) strains from the United States, Europe, New Zealand, and South Africa. Multilocus sequence typing (MLST) analysis was performed on a subset of the strains.

Results: Every strain contained the fhbp gene. All sequences fell into 1 of 2 subfamilies (A or B), with 60%-75% amino acid identity between subfamilies and at least 83% identity within each subfamily. One fHBP sequence may have arisen via inter-subfamily recombination. Subfamily B sequences were found in 70% of the isolates, and subfamily A sequences were found in 30%. Multiple fHBP variants were detected in each of the common MLST clonal complexes. All major MLST complexes include strains in both subfamily A and subfamily B.

Conclusions: The diversity of strains observed underscores the importance of studying the distribution of the vaccine antigen itself rather than relying on common epidemiological surrogates such as MLST.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antigens, Bacterial / chemistry
  • Antigens, Bacterial / genetics*
  • Antigens, Bacterial / metabolism
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics*
  • Bacterial Proteins / metabolism
  • Europe / epidemiology
  • Gene Expression Regulation, Bacterial / physiology
  • Genetic Variation*
  • Humans
  • Meningitis, Meningococcal / epidemiology
  • Meningitis, Meningococcal / microbiology*
  • Meningococcal Vaccines / chemistry
  • Meningococcal Vaccines / genetics*
  • Meningococcal Vaccines / metabolism
  • Molecular Sequence Data
  • Neisseria meningitidis, Serogroup B / genetics*
  • Neisseria meningitidis, Serogroup B / immunology
  • Neisseria meningitidis, Serogroup B / metabolism
  • New Zealand / epidemiology
  • South Africa / epidemiology
  • United States / epidemiology

Substances

  • Antigens, Bacterial
  • Bacterial Proteins
  • Meningococcal Vaccines
  • factor H-binding protein, Neisseria meningitidis